Evidence map›Paper›PMID 28937835›Full record

ArticleCurrent eye research2017

Protective effect of sulforaphane against retinal degeneration in the Pde6

Kai Kang, Minzhong Yu

Abstract read
In one paragraph

Article in Current eye research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Sulforaphane and ophthalmic diseases.Food science & nutrition · 2024
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. (Z)-7,4'-dimethoxy-6-hydroxy-aurone-4-O-The Journal of international medical research · 2020
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kai Kanga Department of Ophthalmic Research , Cole Eye Institute, Cleveland Clinic Foundation , Cleveland , OH 44195 , USA.ORCID 0000-0003-2722-0559
Minzhong Yua Department of Ophthalmic Research , Cole Eye Institute, Cleveland Clinic Foundation , Cleveland , OH 44195 , USA.ORCID 0000-0002-3115-8930
Cleveland Clinic · US

Funding

RESOURCE/SERVICE CORE C - MOLECULAR INFORMATICS MODULEP30EY025585 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI BELA ANAND-APTE · 2016 to 2026
$7.7M
NEI NIH HHS P30 EY025585
6 · The paper itself

Abstract

purposeRetinitis pigmentosa (RP) is a group of inherited diseases characterized by the death of rod photoreceptors, followed by the death of cone photoreceptors, progressively leading to partial or complete blindness. Currently no specific treatment is available for RP patients. Sulforaphane (SFN) has been confirmed to be an effective antioxidant in the treatment of many diseases. In this study, we tested the therapeutic effects of SFN against photoreceptor degeneration in Pde6b

methodsrd10 mice and C57/BL6 wild-type (WT) mice were treated with SFN and saline, respectively, from P6 to P20. Electroretinography (ERG), terminal deoxynucleotidyl transferase dUTP nick end labeling and western blot were tested, respectively, at P21 for the analysis of retinal function, retinal cell apoptosis or death and the protein express of GRP78/BiP (TUNEL) as a marker of endoplasmic reticulum (ER) stress.

resultsCompared with the saline group, the SFN-treated group showed significantly higher ERG a-wave and b-wave amplitudes, less photoreceptor death, and the downregulation of GRP78/BiP.

conclusionsOur data showed that SFN ameliorated the retinal degeneration of rd10 mice, which is possibly related to the downregulation of GRP78 expression.

Indexed as

Disease Models, AnimalAnimalsAnimals, NewbornAntioxidantsApoptosisBlotting, WesternCell SurvivalCyclic Nucleotide Phosphodiesterases, Type 6Down-RegulationElectroretinographyEndoplasmic Reticulum Chaperone BiPEndoplasmic Reticulum StressHeat-Shock ProteinsIn Situ Nick-End LabelingIsothiocyanatesMiceAntioxidantsCyclic Nucleotide Phosphodiesterases, Type 6Endoplasmic Reticulum Chaperone BiPHeat-Shock ProteinsHspa5 protein, mouseIsothiocyanatessulforaphaneSulfoxidesAntioxidantendoplasmic reticulum stressrd10 miceretinitis pigmentosaSulforaphane

Identifiers

PMID28937835
PMCPMC5919295
OpenAlexW2758782039

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.